• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesicles.抗纤维蛋白溶酶的丝氨酸蛋白酶抑制剂 1(PAI-1)被靶向到儿茶酚胺储存小泡中并从其中释放。
Blood. 2011 Jun 30;117(26):7155-63. doi: 10.1182/blood-2010-05-287672. Epub 2011 May 19.
2
Tissue plasminogen activator (t-PA) is targeted to the regulated secretory pathway. Catecholamine storage vesicles as a reservoir for the rapid release of t-PA.组织型纤溶酶原激活物(t-PA)定位于调节性分泌途径。儿茶酚胺储存囊泡作为t-PA快速释放的储存库。
J Biol Chem. 1997 Jan 17;272(3):1976-82. doi: 10.1074/jbc.272.3.1976.
3
Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion.纤溶酶对嗜铬粒蛋白A的加工为调节儿茶酚胺分泌提供了一种新机制。
J Clin Invest. 2000 Oct;106(7):907-15. doi: 10.1172/JCI7394.
4
The chromogranin A fragment catestatin: specificity, potency and mechanism to inhibit exocytotic secretion of multiple catecholamine storage vesicle co-transmitters.嗜铬粒蛋白A片段癌抑素:抑制多种儿茶酚胺储存囊泡共递质胞吐分泌的特异性、效力及机制
J Hypertens. 2006 May;24(5):895-904. doi: 10.1097/01.hjh.0000222760.99852.e0.
5
Slow fusion pore expansion creates a unique reaction chamber for co-packaged cargo.缓慢的融合孔扩张为共包封货物创造了一个独特的反应室。
J Gen Physiol. 2017 Oct 2;149(10):921-934. doi: 10.1085/jgp.201711842. Epub 2017 Sep 7.
6
Unique secretory dynamics of tissue plasminogen activator and its modulation by plasminogen activator inhibitor-1 in vascular endothelial cells.组织型纤溶酶原激活剂在血管内皮细胞中的独特分泌动力学及其受纤溶酶原激活剂抑制剂-1的调节
Blood. 2009 Jan 8;113(2):470-8. doi: 10.1182/blood-2008-03-144279. Epub 2008 Oct 15.
7
Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells.血管紧张素II可增加培养的大鼠主动脉平滑肌细胞中1型纤溶酶原激活物抑制剂和组织型纤溶酶原激活物信使核糖核酸的水平。
Circulation. 1994 Jul;90(1):362-8. doi: 10.1161/01.cir.90.1.362.
8
Plasminogen activator inhibitor-1 is a major stress-regulated gene: implications for stress-induced thrombosis in aged individuals.纤溶酶原激活物抑制剂-1是一种主要的应激调节基因:对老年个体应激诱导的血栓形成的影响。
Proc Natl Acad Sci U S A. 2002 Jan 22;99(2):890-5. doi: 10.1073/pnas.022608799. Epub 2002 Jan 15.
9
Chromogranin B gene ablation reduces the catecholamine cargo and decelerates exocytosis in chromaffin secretory vesicles.嗜铬粒蛋白 B 基因缺失减少了嗜铬细胞分泌小泡中的儿茶酚胺货物并减缓了胞吐作用。
J Neurosci. 2010 Jan 20;30(3):950-7. doi: 10.1523/JNEUROSCI.2894-09.2010.
10
Modulation of tissue plasminogen activator and plasminogen activator inhibitor-1 by transforming growth factor-beta in human retinal glial cells.转化生长因子-β对人视网膜神经胶质细胞中组织型纤溶酶原激活物和纤溶酶原激活物抑制剂-1的调节作用
Invest Ophthalmol Vis Sci. 2002 Aug;43(8):2799-805.

引用本文的文献

1
An Incidental Finding of a Large Pheochromocytoma in an Asymptomatic Male: A Case Report.一名无症状男性偶然发现巨大嗜铬细胞瘤:病例报告
Cureus. 2024 Dec 13;16(12):e75659. doi: 10.7759/cureus.75659. eCollection 2024 Dec.
2
Evaluating CXCL12 for Effects on Reactive Gene Expression in Primary Astrocytes.评估 CXCL12 对原代星形胶质细胞中反应性基因表达的影响。
J Mol Neurosci. 2024 May 28;74(2):57. doi: 10.1007/s12031-024-02231-5.
3
Basal and Stress-Induced Network Activity in the Adrenal Medulla .肾上腺髓质的基础和应激诱导的网络活动。
Front Endocrinol (Lausanne). 2022 Jun 20;13:875865. doi: 10.3389/fendo.2022.875865. eCollection 2022.
4
Potential mechanisms of cerebrovascular diseases in COVID-19 patients.新型冠状病毒肺炎患者脑血管病的潜在发病机制。
J Neurovirol. 2021 Feb;27(1):35-51. doi: 10.1007/s13365-021-00948-2. Epub 2021 Feb 3.
5
Neuroendocrine Targeting of Tissue Plasminogen Activator (t-PA).组织型纤溶酶原激活剂(t-PA)的神经内分泌靶向作用
J Neurol Disord Stroke. 2020;7(1). Epub 2020 Feb 12.
6
ST-Segment Elevation Myocardial Infarction Related to Potential Spontaneous Coronary Thrombosis in Pheochromocytoma Crisis.与嗜铬细胞瘤危象中潜在自发性冠状动脉血栓形成相关的 ST 段抬高型心肌梗死。
Front Endocrinol (Lausanne). 2020 Mar 18;11:140. doi: 10.3389/fendo.2020.00140. eCollection 2020.
7
Preoperative Biomarker Panel, Including Fibrinogen and FVIII, Improves Diagnostic Accuracy for Pancreatic Ductal Adenocarcinoma.包括纤维蛋白原和FVIII在内的术前生物标志物组合可提高胰腺导管腺癌的诊断准确性。
Clin Appl Thromb Hemost. 2018 Nov;24(8):1267-1275. doi: 10.1177/1076029618779133. Epub 2018 Jun 4.
8
Slow fusion pore expansion creates a unique reaction chamber for co-packaged cargo.缓慢的融合孔扩张为共包封货物创造了一个独特的反应室。
J Gen Physiol. 2017 Oct 2;149(10):921-934. doi: 10.1085/jgp.201711842. Epub 2017 Sep 7.
9
Microinflammation factors in the common diseases of the heart and kidneys.心肾常见疾病中的微炎症因子
Dis Markers. 2015;2015:470589. doi: 10.1155/2015/470589. Epub 2015 Jan 14.
10
Nocturnal light exposure alters hepatic Pai-1 expression by stimulating the adrenal pathway in C3H mice.夜间光照通过刺激C3H小鼠的肾上腺途径改变肝脏纤溶酶原激活物抑制剂-1(PAI-1)的表达。
Exp Anim. 2014;63(3):331-8. doi: 10.1538/expanim.63.331.

本文引用的文献

1
The ovine urokinase plasminogen activator and its receptor cDNAs: molecular cloning, characterization and expression in various tissues.绵羊尿激酶型纤溶酶原激活剂及其受体cDNA:分子克隆、特性鉴定及在多种组织中的表达
Gene. 2009 Aug 15;443(1-2):158-69. doi: 10.1016/j.gene.2009.04.008. Epub 2009 Apr 21.
2
Metabolic syndrome, haemostasis and thrombosis.代谢综合征、止血与血栓形成。
Thromb Haemost. 2008 Jun;99(6):995-1000. doi: 10.1160/TH07-11-0682.
3
Plasminogen gene expression is regulated by nerve growth factor.纤溶酶原基因表达受神经生长因子调控。
J Thromb Haemost. 2007 Aug;5(8):1715-25. doi: 10.1111/j.1538-7836.2007.02636.x.
4
Multiple biomarkers and the risk of incident hypertension.多种生物标志物与高血压发病风险
Hypertension. 2007 Mar;49(3):432-8. doi: 10.1161/01.HYP.0000256956.61872.aa. Epub 2007 Jan 22.
5
Cell-surface actin binds plasminogen and modulates neurotransmitter release from catecholaminergic cells.细胞表面肌动蛋白结合纤溶酶原并调节儿茶酚胺能细胞的神经递质释放。
J Neurosci. 2006 Dec 13;26(50):13017-24. doi: 10.1523/JNEUROSCI.2070-06.2006.
6
Distribution of sympathetic tissue plasminogen activator (tPA) to a distant microvasculature.交感组织型纤溶酶原激活剂(tPA)向远处微血管系统的分布。
J Neurosci Res. 2005 Mar 15;79(6):727-33. doi: 10.1002/jnr.20366.
7
Catecholamine synthesizing enzymes and their modulation by immobilization stress in knockout mice.儿茶酚胺合成酶及其在基因敲除小鼠中受固定应激的调节作用。
Ann N Y Acad Sci. 2004 Jun;1018:458-65. doi: 10.1196/annals.1296.056.
8
Targeting of tissue plasminogen activator to the regulated pathway of secretion.组织型纤溶酶原激活剂定位于分泌的调节途径。
Trends Cardiovasc Med. 1998 Oct;8(7):306-12. doi: 10.1016/s1050-1738(98)00025-5.
9
Intramural plasminogen activator inhibitor type-1 and coronary atherosclerosis.壁内1型纤溶酶原激活物抑制剂与冠状动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2003 Nov 1;23(11):1979-89. doi: 10.1161/01.ATV.0000091250.53231.4D. Epub 2003 Aug 14.
10
Storage and release of tissue plasminogen activator by sympathetic axons in resistance vessel walls.阻力血管壁中交感神经轴突对组织型纤溶酶原激活物的储存与释放。
Microvasc Res. 2002 Nov;64(3):438-47. doi: 10.1006/mvre.2002.2441.

抗纤维蛋白溶酶的丝氨酸蛋白酶抑制剂 1(PAI-1)被靶向到儿茶酚胺储存小泡中并从其中释放。

The anti-fibrinolytic SERPIN, plasminogen activator inhibitor 1 (PAI-1), is targeted to and released from catecholamine storage vesicles.

机构信息

Department of Medicine, University of California, San Diego, La Jolla, CA 92161, USA

出版信息

Blood. 2011 Jun 30;117(26):7155-63. doi: 10.1182/blood-2010-05-287672. Epub 2011 May 19.

DOI:10.1182/blood-2010-05-287672
PMID:21596853
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3143556/
Abstract

Recent studies suggest a crucial role for plasminogen activator inhibitor-1 (PAI-1) in mediating stress-induced hypercoagulability and thrombosis. However, the mechanisms by which PAI-1 is released by stress are not well-delineated. Here, we examined catecholaminergic neurosecretory cells for expression, trafficking, and release of PAI-1. PAI-1 was prominently expressed in PC12 pheochromocytoma cells and bovine adrenomedullary chromaffin cells as detected by Northern blotting, Western blotting, and specific PAI-1 ELISA. Sucrose gradient fractionation studies and immunoelectron microscopy demonstrated localization of PAI-1 to catecholamine storage vesicles. Secretogogue stimulation resulted in corelease of PAI-1 with catecholamines. Parallel increases in plasma PAI-1 and catecholamines were observed in response to acute sympathoadrenal activation by restraint stress in mice in vivo. Reverse fibrin zymography demonstrated free PAI-1 in cellular releasates. Detection of high molecular weight complexes by Western blotting, consistent with PAI-1 complexed with t-PA, as well as bands consistent with cleaved PAI-1, suggested that active PAI-1 was present. Modulation of PAI-1 levels by incubating PC12 cells with anti-PAI-1 IgG caused a marked decrease in nicotine-mediated catecholamine release. In summary, PAI-1 is expressed in chromaffin cells, sorted into the regulated pathway of secretion (into catecholamine storage vesicles), and coreleased, by exocytosis, with catecholamines in response to secretogogues.

摘要

最近的研究表明,纤溶酶原激活物抑制剂-1(PAI-1)在介导应激诱导的高凝状态和血栓形成中起着关键作用。然而,应激导致 PAI-1 释放的机制还没有很好地阐明。在这里,我们研究了儿茶酚胺能神经分泌细胞中 PAI-1 的表达、运输和释放。通过 Northern blot、Western blot 和特异性 PAI-1 ELISA 检测,PAI-1 在 PC12 嗜铬细胞瘤细胞和牛肾上腺髓质嗜铬细胞中表达明显。蔗糖梯度分级分离研究和免疫电镜显示 PAI-1 定位于儿茶酚胺储存小泡。刺激分泌剂可导致 PAI-1 与儿茶酚胺共同释放。在体内,用束缚应激急性刺激交感肾上腺,观察到血浆 PAI-1 和儿茶酚胺同时增加。反向纤维蛋白溶酶原活性测定显示细胞释放物中有游离的 PAI-1。Western blot 检测到高分子量复合物,与 PAI-1 与 t-PA 结合一致,以及与裂解的 PAI-1 一致的条带,提示存在有活性的 PAI-1。用抗 PAI-1 IgG 孵育 PC12 细胞来调节 PAI-1 水平,可显著减少烟碱介导的儿茶酚胺释放。总之,PAI-1 在嗜铬细胞中表达,被分拣到分泌的调节途径(进入儿茶酚胺储存小泡),并通过胞吐作用与儿茶酚胺共同释放,作为对分泌剂的反应。